Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

doi:10.3390/medicina60081334

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

Medicina (Kaunas, Lithuania) - 16 Aug 2024

Hayashi Yuka, Tajiri Kazuto, Ozawa Tatsuhiko, Angata Kiyohiko, Sato Takashi, Togayachi Akira, Nagashima Izuru, Shimizu Hiroki, Murayama Aiko, Muraishi Nozomu, Narimatsu Hisashi, Yasuda Ichiro

Abstract excerpt

Background and Objectives: The measurement of hepatitis B surface antigen (HBsAg) is essential for managing chronic hepatitis B virus infection (CHB). HBsAg consists of three different surface envelope proteins: large, middle, and small HB surface proteins. However, in clinical practice, it is not common to evaluate each of these HB surface proteins separately. Materials and Methods: In this study, we...

Topics

Humans
Hepatitis B, Chronic
Hepatitis B Surface Antigens
Female
Male
Adult
Middle Aged
Hepatitis B virus
Antibodies, Monoclonal
Protein Precursors
Epitopes
Genotype

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 39202615
DOI: 10.3390/medicina60081334
PMCID: PMC11356368

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.